文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

(A Little) Clarity on Convalescent Plasma for Covid-19.

作者信息

Katz Louis M

机构信息

From the Mississippi Valley Regional Blood Center, Davenport, IA.

出版信息

N Engl J Med. 2021 Feb 18;384(7):666-668. doi: 10.1056/NEJMe2035678. Epub 2021 Jan 13.

DOI:10.1056/NEJMe2035678
PMID:33440086
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7821982/
Abstract
摘要

相似文献

[1]
(A Little) Clarity on Convalescent Plasma for Covid-19.

N Engl J Med. 2021-2-18

[2]
Convalescent plasma for COVID-19 considerations.

Transfus Apher Sci. 2021-2

[3]
Covid-19 convalescent plasma and SARS-CoV-2 viral variants.

Transfus Clin Biol. 2021-8

[4]
Use of Convalescent Plasma in the Management of COVID-19.

Mo Med. 2021

[5]
Implications of Coronavirus Disease 2019 (COVID-19) Antibody Dynamics for Immunity and Convalescent Plasma Therapy.

Clin Infect Dis. 2021-8-2

[6]
[COVID-19: blood sufficiency versus convalescent plasma?].

Rev Med Chil. 2020-6

[7]
Appropriate selection of convalescent plasma donors for COVID-19.

Lancet Infect Dis. 2021-2

[8]
How Safe Is COVID-19 Convalescent Plasma?

Mayo Clin Proc. 2021-8

[9]
Correspondence on 'CONVALESCENT plasma for COVID-19'.

Eur J Clin Invest. 2021-11

[10]
Convalescent plasma therapy in patients with COVID-19.

Transfus Apher Sci. 2021-2

引用本文的文献

[1]
Immunogenic Potential of Selected Peptides from SARS-CoV-2 Proteins and Their Ability to Block S1/ACE-2 Binding.

Viruses. 2025-1-24

[2]
Clinical Course and Factors Associated With Hospital Admission and Mortality among Sars-Cov 2 Patients within Nairobi Metropolitan Area.

medRxiv. 2024-5-15

[3]
Clinical Utility of SARS-CoV-2 Serological Testing and Defining a Correlate of Protection.

Vaccines (Basel). 2023-10-26

[4]
COVID-19: An Overview of SARS-CoV-2 Variants-The Current Vaccines and Drug Development.

Biomed Res Int. 2023

[5]
Antiviral Treatment of Coronavirus Disease-2019 Pneumonia.

Clin Chest Med. 2023-6

[6]
Protective roles and protective mechanisms of neutralizing antibodies against SARS-CoV-2 infection and their potential clinical implications.

Front Immunol. 2023

[7]
Pharmacokinetic and Pharmacodynamic Effects of Polyclonal Antibodies against SARS-CoV2 in Mice.

Viruses. 2022-12-30

[8]
Efficacy of COVID-HIGIV in animal models of SARS-CoV-2 infection.

Sci Rep. 2022-10-10

[9]
Convalescent Plasma for COVID-19: A Single Center Prospective Experience with Serial Antibody Measurements and Review of the Literature.

Pathogens. 2022-8-23

[10]
COVID-19 in Missouri 2020-2021: A Perspective on Origins, Spread & Controversies, Part I.

Mo Med. 2022

本文引用的文献

[1]
Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19.

N Engl J Med. 2021-3-18

[2]
Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults.

N Engl J Med. 2021-2-18

[3]
A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia.

N Engl J Med. 2021-2-18

[4]
Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial).

BMJ. 2020-10-22

[5]
Treatment of Coronavirus Disease 2019 Patients with Convalescent Plasma Reveals a Signal of Significantly Decreased Mortality.

Am J Pathol. 2020-8-11

[6]
Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19: A Randomized Clinical Trial.

JAMA. 2020-8-4

[7]
Anti-influenza immune plasma for the treatment of patients with severe influenza A: a randomised, double-blind, phase 3 trial.

Lancet Respir Med. 2019-9-30

[8]
The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis.

J Infect Dis. 2015-1-1

[9]
Meta-analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment?

Ann Intern Med. 2006-10-17

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索